ChemicalBook > CAS DataBase List > Avanafil

Avanafil

Product Name
Avanafil
CAS No.
330784-47-9
Chemical Name
Avanafil
Synonyms
Stendra;vanafil;4-((3-chloro-4-Methoxybenzyl)aMino)-2-(2-(hydroxyMethyl)pyrrolidin-1-yl)-N-(pyriMidin-2-ylMethyl)pyriMidine-5-carboxaMide;(S)-4-((3-Chloro-4-Methoxybenzyl)aMino)-2-(2-(hydroxyMethyl)pyrrolidin-1-yl)-N-(pyriMidin-2-ylMethyl)pyriMidine-5-carboxaMide;U 53;U-53;D03217;avanfil;AVANAFE;Avanafil
CBNumber
CB91503998
Molecular Formula
C23H26ClN7O3
Formula Weight
483.95
MOL File
330784-47-9.mol
More
Less

Avanafil Property

Melting point:
150-152°C
Density 
1.372
storage temp. 
Sealed in dry,Store in freezer, under -20°C
solubility 
DMSO (Slightly), Methanol (Slightly, Heated)
form 
Solid
pka
11.84±0.46(Predicted)
color 
White to Off-White
InChI
InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1
InChIKey
WEAJZXNPAWBCOA-INIZCTEOSA-N
SMILES
C1(N2CCC[C@H]2CO)=NC=C(C(NCC2=NC=CC=N2)=O)C(NCC2=CC=C(OC)C(Cl)=C2)=N1
CAS DataBase Reference
330784-47-9(CAS DataBase Reference)
More
Less

Safety

HS Code 
29339900
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

Precautionary statements

P280Wear protective gloves/protective clothing/eye protection/face protection.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML2799
Product name
Avanafil
Purity
≥98% (HPLC)
Packaging
100MG
Price
$33.8
Updated
2023/06/20
Sigma-Aldrich
Product number
SML2799
Product name
Avanafil
Purity
≥98% (HPLC)
Packaging
500MG
Price
$127
Updated
2023/06/20
Cayman Chemical
Product number
23024
Product name
Avanafil
Purity
≥98%
Packaging
100mg
Price
$32
Updated
2024/03/01
Cayman Chemical
Product number
23024
Product name
Avanafil
Purity
≥98%
Packaging
250mg
Price
$70
Updated
2024/03/01
Cayman Chemical
Product number
23024
Product name
Avanafil
Purity
≥98%
Packaging
500mg
Price
$116
Updated
2024/03/01
More
Less

Avanafil Chemical Properties,Usage,Production

Description

Avanafil (Zepeed) was approved by the Korean Health Ministry for the treatment of erectile dysfunction (ED) in August 2011. Avanafil is a highly selective type 5 phosphodiesterase (PDE5) inhibitor. Avanafil is reported to be the most selective PDE5 inhibitor on the market. The onset of Tmax and half-life also varies among the marketed PDE5 inhibitors. Sildenafil has a Tmax at 1 h and a half-life of 3–5 h. Vardenafil is somewhat similar with a Tmax of 0.6 h and a half-life of 4–6 h. Tadalafil has the longest half-life among the marketed drugs with a half-life of 17 h. Avanafil has a fast onset of action reaching Tmax in 0.6 h with a half-life of 1.2 h. A synthesis of avanafil (TA-1790) is described in the patent literature. The main elimination route of avanafil is through the bile and feces. Avanafil was also found to be reabsorbed through enterohepatic recirculation.

Chemical Properties

White Solid

Originator

Mitsubishi Tanabe Pharma Corporation (Japan)

Uses

Avanafil is a highly selective PDE5 inhibitor with IC50 of 1 nM.

Uses

A phosphodiesterase (PDE5) inhibitor, used to treat erectile dysfunction.

Definition

ChEBI: A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]pyrimidine-5-carboxylic acid with the amino group of pyrimidin-2-ylmethylamine Used for treatment of erectile dysfunction.

brand name

Zepeed

Clinical Use

Avanafil was originally discovered at Tanabe Seiyaku (now Mitsubishi Tanabe). JW Pharmaceutical (previously Choongwae Pharma) and VIVUS have since developed and launched avanafil, which is an oral PDE5 inhibitor for the treatment of erectile dysfunction (ED). Although many marketed PDE5 inhibitors (e.g. sildenafil, vardenafil and tadalafil) are available for the treatment of ED, many patients are still unable to achieve the desired results and experience undesired side-effects with these existing medications. As such, second-generation PDE5 inhibitors with enhanced PDE5 selectivity, shorter systemic half-lives, and improved tolerability are desired. Developed to meet these criteria, Avanafil exhibited good oral bioavailability and PDE5 selectivity in both preclinical studies and clinical trials. Avanafil had a short onset of action (35 min) and short half-life (1.5 h).

Synthesis

The synthesis presented is based on the published patent procedure and is outlined in the scheme. Commercially available 4-chloro-2-(methylsulfanyl)pyrimidine- 5-carboxylic acid ethyl ester (25) was treated with 3- chloro-4-methoxybenzylamine (26) and triethylamine at room temperature to give 4-benzylaminopyrimidine derivative 27 in 96% yield. Sulfide 27 was then oxidized with m-chloroperbenzoic acid (m-CPBA), followed bytreatment with L-prolinol and triethylamine to afford ethyl pyrimidinate 28 in 83% yield. This ester was then saponified with 10% sodium hydroxide to give pyrimidine- 5-carboxylic acid 29 in 80% yield, which then underwent conventional amide bond formation using 2-(aminomethyl) pyrimidine (29a), N-(3-dimethylaminopropal)-N0-ethylcarbodiimide hydrochloride (EDCI) and 1-hydroxybenzotriazole hydrate (HOBt) to give avanafil (IV) in 83% yield.

Drug interactions

Potentially hazardous interactions with other drugs
Alpha-blockers: enhanced hypotensive effect - maximum dose 50 mg.
Antibacterials: concentration possibly increased by clarithromycin and telithromycin - avoid; concentration increased by erythromycin - reduce avanafil dose; concentration reduced by rifampicin - avoid.
Antifungals: concentration increased by ketoconazole - avoid and fluconazole - reduce avanafil dose; concentration possibly increased by itraconazole and voriconazole - avoid.
Antivirals: concentration possibly increased by atazanavir, indinavir and saquinavir - avoid; concentration possibly reduced by efavirenz - avoid; concentration possibly increased by fosamprenavir - reduce avanafil dose; concentration significantly increased by ritonavir - avoid.
Aprepitant: concentration possibly increased by aprepitant - reduce avanafil dose.
Calcium channel blockers: concentration possibly increased by diltiazem and verapamil - reduce avanafil dose.
Cobicistat: concentration of avanafil possibly increased - avoid.
Nicorandil: possibly enhanced hypotensive effect - avoid.
Nitrates: enhanced hypotensive effect - avoid.
Riociguat: possibly enhanced hypotensive effect - avoid.

Metabolism

Avanafil is metabolised in the liver mainly by the cytochrome P450 isoenzyme CYP3A4 and to a minor extent by the CYP2C isoform. Two major metabolites are produced, one of which is active. Avanafil is excreted as metabolites mainly in the faeces (approximately 63%) in the urine (approximately 21%).

References

[1] kotera j, mochida h, inoue h, noto t, fujishige k, sasaki t, kobayashi t, kojima k, yee s, yamada y, kikkawa k, omori k. avanafil, a potent and highly selective phosphodiesterase-5 inhibitor for erectile dysfunction. j urol. 2012 aug;188(2):668-74.
[2] cui ys, li n, zong ht, yan hl, zhang y. avanafil for male erectile dysfunction: a systematic review and meta-analysis. asian j androl. 2014 may-jun;16(3):472-7.

Avanafil Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Avanafil Suppliers

Australia 1 Canada 3 China 413 India 10 Poland 1 United Kingdom 3 United States 20 Global 451
Shandong Wankang Biotechnology Co. , Ltd.
Tel
131-7317-1119 13173171119
Email
918582503@qq.com
Country
China
ProdList
25
Advantage
58
Jinan Cheminn Chemicals Co., Ltd.
Tel
531-67875205 15726170169
Fax
+86-531-67875205
Email
sales@cheminn.com
Country
China
ProdList
60
Advantage
60
Taizhou Tongxin Bio-Tech Co., Ltd
Tel
0523-18601685-898 18652728585
Email
sales@allyrise.com
Country
China
ProdList
2782
Advantage
60
Jinan Hongwan Biotechnology Co., Ltd.
Tel
0531-58767175 13220585822
Email
1256200339@qq.com
Country
China
ProdList
35
Advantage
58
Chengdu Aupone Pharmaceutical Co.,Ltd.
Tel
18980796919
Email
236656639@qq.com
Country
China
ProdList
23
Advantage
58
haerbinhake
Tel
18646366731
Email
280028727@qq.com
Country
China
ProdList
49
Advantage
58
Nanjing CoreTech Biomedical Co,.Ltd
Tel
025-52880806 13770327895
Fax
86-025-52880803
Email
API@core-tech.com.cn
Country
China
ProdList
84
Advantage
58
Chengdu Pengshengyue Pharmaceutical Technology Co. , Ltd.
Tel
171-5642-2032 19587414261
Email
3795342424@qq.com
Country
China
ProdList
23
Advantage
58
Wuhan ninety thousand lithium industry and trade Co., LTD
Tel
18627068784
Email
524770880@qq.com
Country
China
ProdList
225
Advantage
58
Shandong Boyi Biotechnology Co., Ltd
Tel
19025109915 19025109915
Email
726504835@qq.com
Country
China
ProdList
130
Advantage
58
More
Less

View Lastest Price from Avanafil manufacturers

Dorne Chemical Technology co. LTD
Product
Avanafil 330784-47-9
Price
US $10.00/ASSAYS
Min. Order
1ASSAYS
Purity
99%
Supply Ability
100kg
Release date
2024-03-26
Jinan Million Pharmaceutical Co., Ltd
Product
Avanafil 330784-47-9
Price
US $1.00/kg
Min. Order
0.10000000kg
Purity
99%
Supply Ability
200KG
Release date
2024-08-21
Guangzhou Tosun Pharmaceutical Ltd
Product
Avanafil 330784-47-9
Price
US $0.00-0.00/kg
Min. Order
5kg
Purity
98%-102%
Supply Ability
200kg
Release date
2024-12-25

330784-47-9, AvanafilRelated Search:

POLY(ETHYLENE GLYCOL) METHYL ETHER ACRYLATE Methoxydiethylborane Tris(hydroxymethyl)aminomethane 6-Aminocaproic acid Methoxyacetic acid p-Anisidine Guaiacol p-Anisaldehyde m-Anisyl alcohol 3-Aminophenol Glycine ALTRENOGEST (Trifluoromethoxy)benzene Anisole Difluorochloromethane Avanafil iMpurity 1 Avanafil Impurity 9 4-(4-MethoxybenzylaMino)-5-ethoxycarbonyl-2-MethylthiopyriMidine

  • 4-[[(3-Chloro-4-Methoxyphenyl)Methyl] aMino]-2-[(2S)-2-(hydroxyMethyl)-1-pyrrolidinyl]-N-(2-pyriMidinylMethyl)-5-pyriMidinecarboxaMide
  • 4-((3-chloro-4-Methoxybenzyl)aMino)-2-(2-(hydroxyMethyl)pyrrolidin-1-yl)-N-(pyriMidin-2-ylMethyl)pyriMidine-5-carboxaMide
  • Avanafil PDE5 inhibitor
  • vanafil
  • (S)-4-((3-Chloro-4-Methoxybenzyl)aMino)-2-(2-(hydroxyMethyl)pyrrolidin-1-yl)-N-(pyriMidin-2-ylMethyl)pyriMidine-5-carboxaMide
  • Avanafil 4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide
  • avanfil
  • (S)-4-((3-Chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-N-(pyrimidin-2-yl
  • avanafil:4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)-1-pyrrolidinyl)-n-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide: (s)-2-(2-hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylami
  • (S)-4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2pyrimidinylmethyl)-5-pyrimidinecarboxamide
  • (S)-2-(2-Hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[(2-pyrimidinylmethyl)carbamoyl]pyrimidine
  • 4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide
  • Avanafil
  • Avanafil (usan/inn)
  • D03217
  • pharmaceutical raw material suppliers Avanafil 330784-47-9 high quality lower Prices
  • Natural Sex Steroid Hormones Avanafil Hormone Powder C23H26ClN7O3 CAS 330784-47-9
  • Avanafil-d3
  • 4-[(3-Chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
  • Avanafil(TA-1790)
  • 4-[(3-Chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide
  • Stendra
  • [13C5, 15N]-Avanafil
  • 4-[(3-Chloro-4-methoxybenzyl)amino]
  • O cut the non
  • AVANAFE
  • Avanafil white powder
  • Avanafil USP/EP/BP
  • Avanafil, Standa
  • Avanafil , Stendra
  • (S)-4-chloro-6-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
  • 4-[(3-Chloro-4-methoxybenzyl)amino] Avanafil
  • Avanafil-d4
  • (S)-4-chloro-6-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-N-(pyrimidin-2-ylmethyl)pyrimidine-6-carboxamide
  • Avanafil 13C5 15NQ: What is Avanafil 13C5 15N Q: What is the CAS Number of Avanafil 13C5 15N Q: What is the storage condition of Avanafil 13C5 15N Q: What are the applications of Avanafil 13C5 15N
  • AvanafilQ: What is Avanafil Q: What is the CAS Number of Avanafil Q: What is the storage condition of Avanafil Q: What are the applications of Avanafil
  • U 53
  • U-53
  • 4-[(3-Chloro-4-methoxybenzyl)amino]-2-[(S)-2-(hydroxymethyl)-1-pyrrolidyl]-N-[(2-pyrimidyl)methyl]-5-pyrimidinecarboxamide
  • Avanafil invoicing name: 4- [[(3-chloro-4-methoxyphenyl) methyl] amino] -2- [(2S) -2-hydroxymethyl-1-pyrrolidine] -5-pyrimidine carboxylate ethyl ester
  • 330784-47-9
  • C23H26ClN7O3
  • Avanafil
  • Inhibitor
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • API
  • Aromatics
  • Chiral Reagents
  • Heterocycles
  • Inhibitors
  • 330784-47-9